BD Vascular Access and Hazardous Drug Safety

Evidence-based webinars from healthcare experts to enhance knowledge and strengthen skills
BD Vascular Access and Hazardous Drug Safety

Ready to learn more? Let’s have a conversation.

Vascular access management webinars

Speaker

Title

Description

CE credit

Recording

Barb Nickel, APRN-CNS, CCN CRNI

2024 Infusion Nurses Society Infusion Therapy Standards of Practice Overview of 9th EditionEvidence-based infusion therapy practice is essential to optimize patient outcomes in critical care. Infusion Nurses Society Infusion Therapy Standards of Practice are evidence-based clinical guidelines designed to promote positive outcomes in areas such as site selection, device management, infusate administration, quality improvement, and patient advocacy. The Standards are used globally in settings from home care to critical care and address best practice recommendations for infusates, devices, and routes of delivery. This foundational presentation will describe the methodology used to revise the 2024 Standards, illustrate application of selected standards, and identify research priorities.N/ARegister now for our March 14 webinar!

Max Holder MSN, RN, CRNI, NE-BC, VA-BC

Developing, growing and enhancing Vascular Access Teams

Approximately one billion VADs are placed worldwide annually1 with up to 85-90% of all hospitalized patients undergoing IV therapy2,3, resulting in substantial healthcare expenditures2

Given the potential clinical and financial benefits of optimized vascular access (VA) practice, there is an imperative to establish VA teams (VATs) with expertise in VAD selection, placement, and management4

This presentation will review strategies for developing, growing, and optimizing Vascular Access Teams while demonstrating the potential enhancements around clinical and economic outcomes.

N/ARegister now for our February 22 webinar

Brian Pendleton, RN, MSN and Michele Acito, DNP, RN, NE-BC, NP-C

One Stick Hospital Stay – Key Elements for Advancing Practice and the Vision

Peripheral IV insertion and blood collection are two of the most common inpatient procedures in US hospitals that touch almost every patient every day. Current practices are often accepted as the norm.   The hidden cost, clinical quality, and patient experience impacts may be under appreciated and the possibility of a better standard of care may not be envisioned.  

Can we challenge the status quo and transform clinical practice? Is there an opportunity to achieve the vision of a ‘one stick hospital stay’ --- the right IV placed correctly on the first attempt that lasts for the duration of care and can be used for both infusion therapy and blood draws? What does it take to overcome the status quo and implement change?  The ability to drive sustainable change is critical to advancing clinical practice.  But change requires strong leadership and a disciplined and creative approach that balances the need of nurse engagement with demanding workloads and a primary focus on direct patient care.   

N/AWatch now


Dr. Nathan T. Gilmore, MD, MBA
The association between catheter type and dialysis treatments, leading to improved patient experience and outcomesMulticenter studies suggest that more than half of ICU patients and approximately 5–7% of all hospitalized patients are affected by acute kidney injury (AKI), which is characterized by a significant loss in kidney function and is associated with increased mortality. Given the prevalence of AKI among critical care patients, device selection can play a key role in successful dialysis treatments within the ICU for optimal CRRT sessions. Dialysis catheter type may be associated with differences in continuous renal replacement therapy (CRRT) treatment in the critically ill, with potential implications for enhanced patient outcomes and healthcare costs. This presentation will review strategies for proper device selection using data from two U.S.-based ICUs and evaluate the impact of short-term dialysis catheters on multiple dialysis treatment outcomes.   N/AWatch now


Jocelyn Hill, CNS, APN
The needle-free connector; dispel the doubts about displacementNeedle-free connectors were originally designed to improve the safety of healthcare workers by reducing needlestick injuries. Now, NFCs are increasingly being used to mitigate catheter related complications such as central line‒associated bloodstream infection (CLABSIs) and occlusions. There are currently many different designs of NFCs on the market, which can make it difficult to evaluate and chose the right NFC for your facility. This webinar reviews the evolution of NFCs and provides an overview of how the various design of NFCs may impact clinical outcomes. During the webinar, there will be a discussion on NFC displacement and a review of current literature and guidelines, which highlight key design features to consider when selecting a NFC for your facility.N/AWatch now

Dr. Rodrigo Cartin-Ceba, MD, MSc

Barb Nickel,
APRN-CNS,
CRNI, CCRN

Vascular Access Device (VAD) Selection in the Intensive Care Unit (ICU)In the intensive care unit (ICU) setting, vascular access devices (VADs) are required for different purposes, including blood sampling, administration of fluids and medications, injection of contrast medium for diagnostic purposes, and hemodynamic monitoring. Determining the most appropriate vascular access device for a patient can be challenging. As clinicians, it is important to understand the clinical standards and guidelines when caring for critically ill patients and determining the most appropriate vascular access device. Multiple factors need to be considered as part of the assessment process such as infusates, patient acuity, site selection, duration of therapy, and the proper patient positioning upon insertion. This presentation will review strategies for proper device selection, care, and maintenance that may help reduce complications and optimize patient outcomes.1.0 Nursing CEWatch now

Cheryl Campos, DNP, RN-BC, CEN, CPHQ, VA-BC

The Quiet Epidemic of Venous Depletion and a Vision of a ‘One Stick Hospital Stay’Venous depletion and preservation are concepts gaining attention to improve quality of care, reduce inefficiencies and cost while preserving vessel health for future care. Peripheral IV insertion and blood collection are two of the most common inpatient procedures in US hospitals that touch almost every patient every day. Despite up to 90% of hospitalized patients already having peripheral access, we’ve relied on separate venipunctures, an average of 1.6 to 2.2 blood collection episodes per day. For ‘difficult intravenous access’ (DIVA) patients, the challenge is even greater. As the population gets older and lives longer, does each patient’s trip to the hospital increase the risk of vessel depletion? What impact does it have on the patient’s experience? Can we challenge the status quo and transform clinical practice?  And, is there an opportunity to achieve the vision of a ‘one stick hospital stay’ --- the right IV placed correctly on the first attempt that last for the duration of care and can be used for both infusion therapy and blood draws?1.0 Nursing CEWatch now

Dr. Frank A Drews, PhD
 

An examination of human error in healthcare settings. What can we do to mitigate the risk?Human error in hospitals is the third leading cause of death in the United States according to a 2016 study.  Mistakes in medical care can be dangerous resulting in death or serious injury. Even the best clinicians can make errors, but what can be done to minimize them in patient care, especially when procedures are being completed by well-meaning but imperfect humans? This presentation will examine the common contributors to human error and while error is part of our cognitive makeup, research in healthcare settings will be reviewed that highlights steps that can be taken to mitigate or “engineer out” some of that risk.  Dr. Drews examines the surprising impact of common occurrences in your everyday work life like interruptions, multi-tasking and time pressure that may contribute to error. 1.0 Nursing CEWatch now

Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC

Problem or Solution? Clinical Evidence connecting Needle-Free Connectors to Lower Rates of CLABSI and Occlusions

This presentation will look at types of evidence and why "real world studies" reporting actual clinical outcomes are more applicable to clinical practice decisions than laboratory studies. 1.0 Nursing CEWatch now

Marc Stranz, PharmD

Barb Nickel,
APRN-CNS,
CRNI, CCRN

Diving Deep into
Non-cytotoxic Infusates

 

Choosing the appropriate vascular access device to meet the prescribed treatment and duration needs can be challenging. With literally hundreds of intravenous drugs, and no one published central list on known irritants, vesicants, and peripherally compatible infusates, making the right device decision is even more complex to navigate. Additionally, to utilize the GAVeCeLT DAV Expert APP and the MAGIC® APP one must have extensive foundational knowledge of non-cytotoxic infusates. What is an irritant or vesicant? What drugs fit into those categories? What do the guidelines provide for decision-making?  This presentation describes the findings of a research project by three well known clinicians that initiated a review of manufacturer instructions for use and Gaharts 2021 Intravenous Medications for Infusion Complications. As a result, the Infusate Consideration Companion (ICC) tool was developed to assist with device selection and will be introduced and be made available during this session.

1.0 Nursing CE

Watch now

Amanda Lynch BSN, RN, VA-BC

Thomas Savage BSN, RN, CEN, CFRN

Implementing a Vascular Access Team (VAT) at a Rural Community Hospital

This presentation discusses how one hospital developed a vascular access team and conducted a study to demonstrate whether creating a VAT can led to better outcomes for patients through standardization of evidence-based practice, monitoring, and education, combined with an increased number of vascular access device options.

1.0 Nursing CE

Watch now

Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC

Vascular Access Device Care and Management

An overview of the risks associated with VADs in clinical practice and review of how organizations need to evaluate VAD Care and Management against the INS Standards of best practice. A novel evidence-based data collection tool will be introduced which may help drive clinical decisions as they relate to VADS.

1.0 Nursing CE

Watch now

Cheryl Campos, DNP, RN-BC, CEN, CPHQ

Part 2 of a 2-part series: Implementing Guidewire Peripheral IV Technology Hospital Wide to Improve Patient Outcomes

A retrospective analysis following a special program for difficult venous access (DVA) patients. Clinically significant findings were identified including higher first-time attempt success rates, longer catheter dwell times, opportunities for cost savings and prevention of more invasive lines, when guide-wire assisted peripheral IV catheters were inserted by specialty trained nurses. Part 2 of a 2-part series.

1.0 Nursing CE

Watch now

Lynn Hadaway, MEd, RN, NPD-BC, CRNI

Mitigating the Risk of Extravasation with Power Injection

This presentation is based on a literature review and highlights a case study approach to discuss lawsuits involving contrast extravasation, including discussion on techniques for catheter assessment and new technology to reduce this serious complication.

1.0 Nursing CE

Watch now

Hazardous drug safety webinars

SpeakerTitleDescriptionCE creditRecording

MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN

Hazardous Drug Administration from Start to Finish- Have You Considered the DetailsThe presentation will review evidence -based guidelines with a focus on the safe handling of hazardous drugs. Reviewing strategies for administration through disposal as well as strategies to help ensure patients received the prescribed dose while minimizing environmental exposure and protecting healthcare workers.N/AWatch now

Erich Brechtelsbauer, PharmD, MS, BCPS

A Change Worth Making: Implementation of a Novel Closed-System Transfer Device (CSTD) and Point-of-Care Hazardous Drug Detection SystemAccording to the U.S. Centers for Disease Control and Prevention, about 8 million healthcare workers (HCWs) are potentially exposed to hazardous drugs (HD) and minimizing surface contamination is critical for protecting their health. This presentation will describe an approach to select and implement a closed system drug-transfer device (CSTD) in a multisite health-system, review real-world study results on reduction of HD surface contamination, including best practices for ongoing HD detection and monitoring to improve HCW and patient safety.N/AWatch now

Patricia C. Kienle, M.P.A., BCSCP, FASHP

 

Silvia Valero García

Developing HD Contamination Monitoring Guidelines: Global PerspectivesSince the U.S. National Institute for Occupational Safety and Health (NIOSH) Alert on Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings was released in 2004, there has been increased focus worldwide on HD safety. This educational activity will present experiences from practitioners globally as they have worked to develop guidelines and best practice recommendations for HD surface contamination monitoring. The faculty will discuss the process undertaken to develop the guidelines as well as highlight the specific recommendations made.N/AWatch now

Patricia C. Kienle, M.P.A., BCSCP, FASHP

MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN

Safe to Touch: How Nursing and Pharmacy can Partner on HD Surface Contamination MonitoringIn 2020, the Safe to Touch Consensus Conference was convened to develop statements on HD surface contamination monitoring in healthcare settings. These consensus statements provide an opportunity for nursing and pharmacy to collaborate in development and implementation of to improve the safe handling and monitoring of HDs in the healthcare setting. This presentation will review the Safe to Touch Consensus Conference statements and provide a practical, multidisciplinary approach to implementation.1.0 Nursing CEWatch Now

Discover the BD Vascular Access Management program

BD Vascular Access Management is an integrated approach designed to identify and address gaps in the vascular access process that may result in improved clinical outcomes, better patient experiences, and process and economic efficiencies.

Learn More

References

 

  1. Rickard CM, Marsh NM, Webster J, Gavin NC, McGrail MR, Larsen E, et al. Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial). BMJ Open. 2015;5(2):e007257.
  2. Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012;35(2):84-91.
  3. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but Unacceptable: Peripheral IV Catheter Failure. J Infus Nurs. 2015;42(3):151-64.
  4. Pernar LI, Wolf LL, Seshadri A, Patel V. Impact of a Surgeon-Led Peripherally Inserted Central Venous Catheter Team on Peripherally Inserted Central Venous Catheter-Related Complications and Costs. Surg Infect (Larchmt). 2016;17(3):352-6.

 

BD-24411 (12/21)

Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×